Mastocytosis in adults;Mastocitosis del adulto. Descripción de 9 casos clinicopatoló gicos

Actas Dermo-Sifiliograficas

Volumn 96, Issue 4, 2005, Pages 231-236

  Angulo, Jorge ^a,b   Ruiz De La Parte, Ana ^a   González Guerra, Elena ^a   Vargas Machuca, Inmaculada ^a   Fariña, María C ^a   Martín, Lucia ^a   Requena, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Mastocytosis in adults; Mutations in the c kit proto oncogene; Systemic mastocytosis

Indexed keywords

ASPARTIC ACID; VALINE;

ABDOMINAL PAIN; ADULT; AGED; AMINO ACID SUBSTITUTION; ANAPHYLACTIC SHOCK; ARTICLE; BONE; BONE MARROW; CELL INFILTRATION; CLINICAL ARTICLE; CODON; DIARRHEA; DISEASE COURSE; FEMALE; FLUSHING; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MASTOCYTOSIS; NAUSEA; OSTEOPOROSIS; PAPULE; PROGNOSIS; PROTO ONCOGENE; PRURITUS; SYNCOPE; TACHYCARDIA; VOMITING;

EID: 20944451985     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(05)73075-1     Document Type: Article

References (17)

1. Bologna JL, Jorizzo J, Rapini R. Dermatology. Saint Louis: Mosby; 2003. p. 1899-906.
2. Valent P, Horny H-P, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-25.
3. Brockow K, Scott LM, Worobec AS, et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. Arch Dermatol. 2002;138:785-90.
4. Escribano L, Akin C, Castells M, et al. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol. 2002;81:677-90.
5. Tebbe B, Stavropoulos PG, Krasagakis K, Orfanos CE. Cutaneous mastocytosis in adults, evaluation of 14 patients with respect to systemic disease manifestations. Dermatology. 1998;197:101-8.
6. Metcalfe DD. The liver, spleen and lymph nodes in mastocytosis. J Invest Dermatol. 1991;96:455-65.
7. Brockow K, Akin C, Huber M, Metcalfe DD. Assessment of the extent of cutaneous involvement in children and in adults with mastocytosis: relationship to symptomatology, tryptase levels and bone marrow pathology. J Am Acad Dermatol. 2003;48:508-16.
8. Longley BJ, Metcalfe DD, Tharp MD, et al. Activating and dominant inactivatin c-kit catalytic domain mutations indistinct forms of human mastocytosis. Proc Nad Acad Sci U S A. 1999;96:1609-14.
9. Metcalfe DD. The mastocytosis syndrome. En: Freedberg I, Eisen AZ, Wolff K, et al, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 1902-8.
10. Longley BJ, Metcalfe DD. A proposed classification of mastocytosis incorporating molecular genetics. Hematol Oncol Clin North Am. 2000;14:697-700.
11. Sotlar K, Escribano L, Landt O, et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction camping and hybridization probes. AJP 2003;162:737-46.
12. Torrelo A, Navarro L, Escribano L. Diagnóstico, tratamiento y clasificación de la mastocitosis pediátrica. Estudio de 172 casos. Actas Dermosifiliogr. 1998;89:461-76.
13. Frieri M, Ailing DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med. 1985;78:9-14.
14. Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol. 1990;85:852-5.
15. Escribano L, Bravo P, Cantalapiedra A, et al. Aspectos prácticos sobre el diagnóstico y tratamiento de las mastocitosis del adulto. Actas Dermosifiliogr. 1999;99:211-23.
16. Czarnetzki BM, Rosenbach T, Kolde G, Frosch PJ. Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes. Arch Dermatol Res. 1985;277: 105-13.
17. Vella Briffa D, Eady RA, James MP, Gatti S, Bleehen SS. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol. 1983;109:67-75.